STI/RTI | High risk populations | Low risk populations | Low risk WHO estimates 1995 | ||||||
---|---|---|---|---|---|---|---|---|---|
1980s | 1990s | 1980s | 1990s | ||||||
Median (%) | Range (%) | Median (%) | Range (%) | Median (%) | Range (%) | Median (%) | Range (%) | Mean (%) | |
NS = not studied. | |||||||||
Reproduced from: Mayaud72 (with permission). | |||||||||
Sources 1980s: Wasserheit, Holmes.73 | |||||||||
Sources 1990s: Mayaud.72 | |||||||||
Includes the following references: high risk groups: three studies among STI clinic attenders in Benin, Malawi, and Tanzania, with numbers ranging from 192 to 560; and three studies among female sex workers in Cote d’Ivoire, Senegal, and the Democratic Republic of Congo (ex-Zaire), with populations ranging from 374 to 1222; low risk groups: five studies among ANC attenders in Cote d’Ivoire, Gabon, Kenya, Mozambique, Tanzania, and the Democratic Republic of Congo (ex-Zaire), with populations ranging from 201 to 1160; and four studies among family planning attenders in Kenya, Tanzania (two), and South Africa. | |||||||||
Many of the studies can be found in Mindel et al.74 | |||||||||
Source WHO 1995: Gerbase et al.75 | |||||||||
Chlamydia | 14 | 2–25 | 8 | 2–13 | 8 | 1–29 | 7 | 4–18 | 7.1 |
Gonorrhoea | 24 | 7–66 | 16 | 6–31 | 6 | 0.3–40 | 2.3 | 1.6–9 | 2.8 |
Trichomoniasis | 17 | 4–20 | 28 | 11–46 | 12 | 3–50 | 18 | 10–27 | 14.1 |
Syphilis | 15 | 4–32 | 8 | 2–29 | 8 | 0.01–33 | 4.4 | 1–29 | 3.9 |
Candidiasis | NS | NS | 33 | 28–38 | NS | NS | 27 | 7.5–39 | NS |
Bacterial vaginosis | NS | NS | NS | NS | NS | NS | 22 | 15–35 | NS |